BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17418617)

  • 1. Short tandem repeat polymorphism in exon 4 of esophageal cancer related gene 2 predicts relapse of oral squamous cell carcinoma.
    Blessmann M; Kaifi JT; Schurr PG; Cihan A; Kalinin V; Trump F; Atac A; Heiland M; Pohlenz P; Blake F; Schmelzle R; Izbicki JR
    Oral Oncol; 2008 Feb; 44(2):143-7. PubMed ID: 17418617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short tandem repeat polymorphism in exon 4 of esophageal cancer-related gene 2 detected in genomic DNA is a prognostic marker for esophageal cancer.
    Kaifi JT; Rawnaq T; Schurr PG; Yekebas EF; Mann O; Merkert P; Link BC; Kalinin V; Pantel K; Sauter G; Strate T; Izbicki JR
    Am J Surg; 2007 Sep; 194(3):380-4. PubMed ID: 17693286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short tandem repeat polymorphisms of exon 4 in Kazal-type gene ECRG2 in pancreatic carcinoma and chronic pancreatitis.
    Kaifi JT; Cataldegirmen G; Wachowiak R; Schurr PG; Kleinhans H; Kosti G; Yekebas EF; Mann O; Kutup A; Kalinin V; Strate T; Izbicki JR
    Anticancer Res; 2007; 27(1A):69-73. PubMed ID: 17352218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short tandem repeat polymorphism in a novel esophageal cancer-related gene (ECRG2) implicates susceptibility to esophageal cancer in Chinese population.
    Yue CM; Bi MX; Tan W; Deng DJ; Zhang XY; Guo LP; Lin DX; Lu SH
    Int J Cancer; 2004 Jan; 108(2):232-6. PubMed ID: 14639608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single nucleotide polymorphism in esophageal cancer related gene 1: an analysis in resected oral squamous cell carcinoma patients.
    Blessmann M; Pohlenz P; Atac A; Kaifi JT; Eulenburg C; Kalinin V; Merkert P; Smeets R; Heiland M; Blake F; Schmelzle R; Izbicki JR
    Int J Oral Maxillofac Surg; 2009 Jul; 38(7):779-84. PubMed ID: 19394797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between esophageal cancer-related gene 2 polymorphism and esophageal squamous cell carcinomas in Kazakhs and Hans of Xinjiang.
    Gao L; Li J; Zheng Y
    Int J Clin Exp Pathol; 2019; 12(9):3408-3416. PubMed ID: 31934184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite GTn-repeat polymorphism in the promoter of heme oxygenase-1 gene is an independent predictor of tumor recurrence in male oral squamous cell carcinoma patients.
    Vashist YK; Blessmann M; Trump F; Kalinin V; Kutup A; Schneider C; Gawad K; Kaifi JT; Schmelzle R; Izbicki JR; Yekebas EF
    J Oral Pathol Med; 2008 Sep; 37(8):480-4. PubMed ID: 18312299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-1322 regulates ECRG2 allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma.
    Zhang T; Zhao D; Wang Q; Yu X; Cui Y; Guo L; Lu SH
    Mol Carcinog; 2013 Aug; 52(8):581-90. PubMed ID: 22315007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 434(G>C) polymorphism in the eosinophil cationic protein gene and its association with tissue eosinophilia in oral squamous cell carcinomas.
    Pereira MC; Oliveira DT; Olivieri EH; Rogatto SR; Carvalho AL; Landman G; Kowalski LP
    J Oral Pathol Med; 2010 Jan; 39(1):56-62. PubMed ID: 19566743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer.
    Muñoz-Guerra MF; Fernández-Contreras ME; Moreno AL; Martín ID; Herráez B; Gamallo C
    Ann Surg Oncol; 2009 Aug; 16(8):2351-8. PubMed ID: 19449077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage treatment for recurrent oral squamous cell carcinoma.
    Sun GW; Tang EY; Yang XD; Hu QG
    J Craniofac Surg; 2009 Jul; 20(4):1093-6. PubMed ID: 19521259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
    Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
    Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent genetic alterations and reduced expression of the Axin1 gene in oral squamous cell carcinoma: involvement in tumor progression and metastasis.
    Zhou CX; Gao Y
    Oncol Rep; 2007 Jan; 17(1):73-9. PubMed ID: 17143481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infiltrating macrophage count: a significant predictor for the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Lu CF; Huang CS; Tjiu JW; Chiang CP
    Head Neck; 2010 Jan; 32(1):18-25. PubMed ID: 19484765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling gene expression ratios of paired cancerous and normal tissue predicts relapse of esophageal squamous cell carcinoma.
    Ishibashi Y; Hanyu N; Nakada K; Suzuki Y; Yamamoto T; Yanaga K; Ohkawa K; Hashimoto N; Nakajima T; Saito H; Matsushima M; Urashima M
    Cancer Res; 2003 Aug; 63(16):5159-64. PubMed ID: 12941848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
    Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT
    J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of p27 expression in carcinoma of the oral cavity and oropharynx.
    Venkatesan TK; Kuropkat C; Caldarelli DD; Panje WR; Hutchinson JC; Chen S; Coon JS
    Laryngoscope; 1999 Aug; 109(8):1329-33. PubMed ID: 10443844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
    Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMSH2 gene alterations associated with recurrence of oral squamous cell carcinoma.
    Sanguansin S; Petmitr S; Punyarit P; Vorasubin V; Weerapradist W; Surarit R
    J Exp Clin Cancer Res; 2006 Jun; 25(2):251-7. PubMed ID: 16918138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage therapy in relapsed squamous cell carcinoma of the oral cavity: how and when?
    Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; Yen TC
    Cancer; 2008 Jan; 112(1):94-103. PubMed ID: 18022917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.